Indeed, use of glucagon-like peptide 1 (GLP1) analog has been reported to increase the occurrence of cancers in pancreas and colon, suggesting that increase of GLP1 is the culprit for the carcinogenesis27. The gene discussed is GCG; the disease is cancer.